open access

Online first
Short communication
Published online: 2021-12-23
Get Citation

Outcomes of cardiac surgical treatment for carcinoid heart disease

Sonia J Konsek-Komorowska1, Agnieszka D Kolasińska-Ćwikła2, Jacek Różański3, Krzysztof Bartuś4, Jarosław Kuriata3, Marek Konka3, Ewa Sitkowska-Rysiak3, Ilona Michałowska3, Elżbieta Florczak3, Maria Jaworska-Wilczyńska3, Andrzej Januszewicz3, Tomasz Hryniewiecki3, Jarosław B Ćwikła1, Mariola Pęczkowska3
DOI: 10.33963/KP.a2021.0189
·
Pubmed: 34939659
Affiliations
  1. Department of Cardiology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland
  2. The Maria Skłodowska-Curie National Research Institute of Oncology, Warszawa, Poland
  3. National Institute of Cardiology, Warszawa, Poland
  4. Department of Cardiovascular Surgery and Transplantology, Jagiellonian University Medical College, Kraków, Poland

open access

Online first
Short communication
Published online: 2021-12-23

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Outcomes of cardiac surgical treatment for carcinoid heart disease

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Short communication

Published online

2021-12-23

DOI

10.33963/KP.a2021.0189

Pubmed

34939659

Authors

Sonia J Konsek-Komorowska
Agnieszka D Kolasińska-Ćwikła
Jacek Różański
Krzysztof Bartuś
Jarosław Kuriata
Marek Konka
Ewa Sitkowska-Rysiak
Ilona Michałowska
Elżbieta Florczak
Maria Jaworska-Wilczyńska
Andrzej Januszewicz
Tomasz Hryniewiecki
Jarosław B Ćwikła
Mariola Pęczkowska

References (10)
  1. Niederle B, Pape UF, Costa F, et al. ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum. Neuroendocrinology. 2016; 103(2): 125–138.
  2. Gut P, Czarnywojtek A, Sawicka-Gutaj N, et al. Assessment of serotonin concentration in patients with a small-intestine neuroendocrine neoplasm and carcinoid syndrome treated with somatostatin analogues. Pol Arch Intern Med. 2020; 130(10): 903–905.
  3. Nguyen A, Schaff HV, Abel MD, et al. Improving outcome of valve replacement for carcinoid heart disease. J Thorac Cardiovasc Surg. 2019; 158(1): 99–107.e2.
  4. Albåge A, Montibello M. Surgical aspects of valve replacement in carcinoid heart disease. J Card Surg. 2021; 36(1): 290–294.
  5. Bhattacharyya S, Raja SG, Toumpanakis C, et al. Outcomes, risks and complications of cardiac surgery for carcinoid heart disease. Eur J Cardiothorac Surg. 2011; 40(1): 168–172.
  6. Mokhles P, van Herwerden LA, de Jong PL, et al. Carcinoid heart disease: outcomes after surgical valve replacement. Eur J Cardiothorac Surg. 2012; 41(6): 1278–1283.
  7. Edwards NC, Yuan M, Nolan O, et al. Effect of valvular surgery in carcinoid heart disease: an observational cohort study. J Clin Endocrinol Metab. 2016; 101(1): 183–190.
  8. Florczak E, Pęczkowska M, Konka M, et al. A 51-year-old patient with carcinoid heart disease and severe tricuspid regurgitation. Kardiol Pol. 2017; 75(2): 183.
  9. Hahn RT, Kodali S, Fam N, et al. Early multinational experience of transcatheter tricuspid valve replacement for treating severe tricuspid regurgitation. JACC Cardiovasc Interv. 2020; 13(21): 2482–2493.
  10. Rdzanek A, Szymański P, Gackowski A, et al. Percutaneous tricuspid edge-to-edge repair - patient selection, imaging considerations, and the procedural technique. Expert opinion of the Working Group on Echocardiography and Association of CardioVascular Interventions of the Polish Cardiac Society. Kardiol Pol. 2021; 79(10): 1178–1191.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl